TYBR Health, Inc. — SEC Form D Filing

TYBR Health, Inc. filed an SEC Form D on July 22, 2026, reporting $14.35M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
July 22, 2026
Amount reported
$14.35M
Round stage
Pre-Seed
Industry
Medical Devices
Website
https://www.tybrhealth.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

After tendon repair surgery, up to 40% of patients experience lifelong mobility limitations due to the body's healing response, leading to a gap between surgical success and functional recovery.

Solution

TYBR Health aims to improve functional recovery for tendon repair patients by addressing the gap between surgical success and the body's healing response, though the specific mechanism is not detailed on the provided content.

Verdict

Investors backed this company primarily due to the clear and substantial downstream consequences of current tendon repair limitations, not the detailed specifics of their proposed solution. The implicit bet was on the team's ability to translate a general medical need into a clinically viable and regulatory-approvable device. Upside was inherently limited by the typical development cycles and regulatory hurdles in medical devices, which constrain rapid scale and exit velocity compared to software plays.

Source: SEC EDGAR Form D filing